Literature DB >> 20089790

Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older.

Ramón A Durazo-Arvizu1, Bess Dawson-Hughes, Christopher T Sempos, Elizabeth A Yetley, Anne C Looker, Guichan Cao, Susan S Harris, Vicki L Burt, Alicia L Carriquiry, Mary Frances Picciano.   

Abstract

The concentration or threshold of 25-hydroxyvitamin D [25(OH)D] needed to maximally suppress intact serum parathyroid hormone (iPTH) has been suggested as a measure of optimal vitamin D status. Depending upon the definition of maximal suppression of iPTH and the 2-phase regression approach used, 2 distinct clusters for a single 25(OH)D threshold have been reported: 16-20 ng/mL (40-50 nmol/L) and 30-32 ng/mL (75-80 nmol/L). To rationalize the apparently disparate published results, we compared thresholds from several regression models including a 3-phase one to estimate simultaneously 2 thresholds before and after adjusting for possible confounding for age, BMI, glomerular filtration rate, dietary calcium, and season (April-September vs. October-March) within a single data set, i.e. data from the Tufts University Sites Testing Osteoporosis Prevention/Intervention Treatment study, consisting of 181 men and 206 women (total n = 387) ages 65-87 y. Plasma 25(OH)D and serum iPTH concentrations were (mean +/- SD) 22.1 +/- 7.44 ng/mL (55.25 +/- 18.6 nmol/L) and 36.6 +/- 16.03 pg/mL (3.88 +/- 1.7 pmol/L), respectively. The 3-phase model identified 2 thresholds of 12 ng/mL (30 nmol/L) and 28 ng/mL (70 nmol/L); similar results were found from the 2-phase models evaluated, i.e. 13-20 and 27-30 ng/mL (32.5-50 and 67.5-75 nmol/L) and with previous results. Adjusting for confounding did not change the results substantially. Accordingly, the 3-phase model appears to be superior to the 2-phase approach, because it simultaneously estimates the 2 threshold clusters found from the 2-phase approaches along with estimating confidence limits. If replicated, it may be of both clinical and public health importance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089790      PMCID: PMC2821888          DOI: 10.3945/jn.109.116681

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  16 in total

1.  Too little vitamin D in premenopausal women: why should we care?

Authors:  Michael F Holick
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

2.  Serum 25-hydroxyvitamin D and parathyroid hormone exhibit threshold behavior.

Authors:  R P Heaney
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

3.  Redefining vitamin D insufficiency.

Authors:  A Malabanan; I E Veronikis; M F Holick
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

4.  Dietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites.

Authors:  H K Kinyamu; J C Gallagher; K A Rafferty; K E Balhorn
Journal:  Am J Clin Nutr       Date:  1998-02       Impact factor: 7.045

5.  Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group.

Authors:  M C Chapuy; A M Schott; P Garnero; D Hans; P D Delmas; P J Meunier
Journal:  J Clin Endocrinol Metab       Date:  1996-03       Impact factor: 5.958

6.  A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum.

Authors:  M A Preece; J L O'Riordan; D E Lawson; E Kodicek
Journal:  Clin Chim Acta       Date:  1974-07-31       Impact factor: 3.786

7.  Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women.

Authors:  B Dawson-Hughes; S S Harris; G E Dallal
Journal:  Am J Clin Nutr       Date:  1997-01       Impact factor: 7.045

8.  Vitamin D status during puberty in French healthy male adolescents.

Authors:  J Guillemant; P Taupin; H T Le; N Taright; A Allemandou; G Pérès; S Guillemant
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

9.  Hypovitaminosis D in medical inpatients.

Authors:  M K Thomas; D M Lloyd-Jones; R I Thadhani; A C Shaw; D J Deraska; B T Kitch; E C Vamvakas; I M Dick; R L Prince; J S Finkelstein
Journal:  N Engl J Med       Date:  1998-03-19       Impact factor: 91.245

10.  Summary of roundtable discussion on vitamin D research needs.

Authors:  Patsy M Brannon; Elizabeth A Yetley; Regan L Bailey; Mary Frances Picciano
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

View more
  27 in total

Review 1.  Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D.

Authors:  Christopher T Sempos; Annemieke C Heijboer; Daniel D Bikle; Jens Bollerslev; Roger Bouillon; Patsy M Brannon; Hector F DeLuca; Glenville Jones; Craig F Munns; John P Bilezikian; Andrea Giustina; Neil Binkley
Journal:  Br J Clin Pharmacol       Date:  2018-07-17       Impact factor: 4.335

2.  Association of Vitamin D and Parathyroid Hormone Levels in Overweight and Obese Adolescents.

Authors:  Aparna Varma Bhongir; S M Vijaitha; Sravanthi Kuruguntla; Padma Yalamati; Sapna Vyakaranam
Journal:  Indian J Clin Biochem       Date:  2018-07-11

3.  Vitamin D and Major Chronic Illness.

Authors:  Sadeq A Quraishi; Carlos A Camargo
Journal:  J Restor Med       Date:  2012-09

4.  Higher Vitamin D Levels Are Associated with Better Attentional Functions: Data from the NorCog Register.

Authors:  J Zugic Soares; R Pettersen; J Saltyte Benth; A B Knapskog; G Selbæk; N Bogdanovic
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 5.  The impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials.

Authors:  E K Calton; K N Keane; P Newsholme; Y Zhao; M J Soares
Journal:  Eur J Clin Nutr       Date:  2017-05-10       Impact factor: 4.016

6.  Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.

Authors:  J Tamaki; M Iki; Y Sato; E Kajita; H Nishino; T Akiba; T Matsumoto; S Kagamimori
Journal:  Osteoporos Int       Date:  2017-02-27       Impact factor: 4.507

7.  IOF position statement: vitamin D recommendations for older adults.

Authors:  B Dawson-Hughes; A Mithal; J-P Bonjour; S Boonen; P Burckhardt; G E-H Fuleihan; R G Josse; P Lips; J Morales-Torres; N Yoshimura
Journal:  Osteoporos Int       Date:  2010-04-27       Impact factor: 4.507

8.  Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism.

Authors:  Marcella D Walker; Elaine Cong; Anna Kepley; Marco R Di Tullio; Tatjana Rundek; Shunichi Homma; James A Lee; Rui Liu; Polly Young; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

9.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 10.  Vitamin D in acute stress and critical illness.

Authors:  Sadeq A Quraishi; Carlos A Camargo
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-11       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.